Page 2 - Med Sci News Today

/PRNewswire/ -- "One benefit from this type of analysis is that it provides an opportunity to engage in more directed discussions aimed at confronting these...

Teclistamab, an off-the-shelf (ready to use) subcutaneously administered therapy, induced deep and rapid responses in triple-class exposed patients with relapsed and refractory multiple myeloma1 The

/PRNewswire/ -- The condition called is Bells palsy, which results in facial paralysis. It is a form of facial paralysis that results from trauma or damaged...

/PRNewswire/ -- At least 5% of Americans suffer from chronic low back pain. [1] Over $630 billion is spent annually on costs to society [2], and chiropractic...

Series of pain management tracks across 3 countries offer an extensive multidisciplinary agenda that includes chiropractic technique, technological in

Press release content from Business Wire. The AP news staff was not involved in its creation.

Teclistamab is the first T-cell redirecting bispecific antibody to receive a positive CHMP opinion for adults with RRMM and highlights Janssen's commitment to innovation in multiple myeloma The

Assessing key research trends in virtual learning during the COVID-19 pandemic through a bibliometric analysis of 1595 studies from 589 journals during 2020-21

Will a time-tested intervention such as acupuncture point your health in the right direction, or is it a ...

Why protecting the ‘master controller’ of our metabolism is key to health and wellbeing; and how classing thyroid disorders as noncommunicable diseases (NCDs) can help.